T1	Chemical 32 40	low-dose
T2	Disease 77 92	prostate cancer
T3	Chemical 97 111	antiangiogenic
T6	Disease 208 235	haematological malignancies
T7	Chemical 272 289	angiogenic agents
T8	Chemical 300 304	bFGF
T9	Chemical 306 310	VEGF
T10	Chemical 315 319	IL-6
T12	Disease 445 460	prostate cancer
T13	Chemical 572 597	prostate-specific antigen
T16	Chemical 634 638	bFGF
T17	Chemical 643 647	VEGF
T19	Chemical 874 878	bFGF
T20	Chemical 883 887	VEGF
T21	Disease 909 928	progressive disease
T22	Chemical 1002 1006	bFGF
T23	Chemical 1011 1015	VEGF
T24	Chemical 1091 1105	growth factors
T25	Disease 1107 1122	Adverse effects
T27	Disease 1146 1164	morning drowsiness
T31	Disease 1254 1283	peripheral sensory neuropathy
T33	Disease 1412 1433	peripheral neuropathy
T35	Disease 1673 1694	peripheral neuropathy
